Effects of intragastric and intravenous glucose on restraint model of stress ulceration.
Intragastric glucose prevents acute stress-induced gastric mucosal injury in the restrained rat. Because increased gastric contractions contribute to mucosal injury in this model and because parenteral glucose infusions have been shown to suppress gastric contractility, we hypothesized that centrally mediated responses to hyperglycemia might contribute to the cytoprotective effect of intragastric glucose. We compared intragastric and intravenous 25% glucose with saline infusions during cold restraint and measured their impact on gastric lesions, serum glucose levels, gastric residual volume (an indirect indicator of net gastric contractility), acidity, and mucin concentration. We found that both intravenous and intragastric glucose infusions increased serum glucose to over 500 mg/dl after 4 hr of stress. Intragastric glucose increased residual volume and gastric pH, as well as decreased gastric mucosal injury, but intravenous glucose had no effects on gastric function. We found that none of the potentially protective effects of intragastric glucose are mediated by central responses to hyperglycemia, and likewise that intravenous glucose has no effect on gastric mucosal injury.
Kleiman-Wexler
R L
RL
Division of Clinical Pharmacy, College of Pharmacy, University of Iowa, Iowa City 52242.
Ephgrave
K S
KS
Broadhurst
K A
KA
D000818:Animals; D001786:Blood Glucose / Q000502:physiology; D005745:Gastric Acidity Determination; D005766:Gastrointestinal Contents; D005769:Gastrointestinal Motility; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D007262:Infusions, Intravenous; D007441:Intubation, Gastrointestinal; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013276:Stomach Ulcer / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D013312:Stress, Physiological / Q000150:complications*
D001786:Blood Glucose; D005947:Glucose